Isofol Medical AB
- Biotech or pharma, therapeutic R&D
Biotech Company developing arfolitixorin for treatment of patients with metastatic colorectal (mCRC) cancer. Arfolitixorin is to be used whenever 5-FU is used in mCRC. Phase III trial aim to demonstrate improvement compared to current SOC.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}